VOLUME 5, NUMBER 33 |
September 19, 2016 |
|||||||||||||
FDA clinical trials principally are developed to determine if a drug or device can demonstrate safety and efficacy. However, they also provide a potential treatment avenue for patients with sight-threatening diseases at times when no other options may exist. |
||||||||||||||
The website www.ClinicalTrials.gov is an invaluable resource for clinicians who are interested in learning more about recently completed and ongoing studies of novel drugs, devices and other treatment options used to manage a host of disease states. Many of the ongoing studies listed are on the site are actively recruiting and enrolling participants. Having an opportunity to test the viability of emerging treatment options can provide hope patients with rare or recalcitrant conditions.
|
||||||||||||||
"To know what you prefer instead of humbly saying Amen to what the world tells you ought to prefer is to have kept your soul alive" |
||||||||||||||
Review of Optometry® is published by the Review Group, a Division of Jobson Medical Information LLC (JMI), 11 Campus Boulevard, Newtown Square, PA 19073. To subscribe to other JMI newsletters or to manage your subscription, click here. To change your email address, reply to this email. Write "change of address" in the subject line. Make sure to provide us with your old and new address. To ensure delivery, please be sure to add revoptom@lists.jobsonmail.com to your address book or safe senders list. Click here if you do not want to receive future emails from Review of Optometry. |